Joseph Frank Oldakowski, the Chief Accounting Officer of Clover Health Investments, has been awarded a substantial stock grant, as detailed in a recent SEC filing. This move is significant as it aligns the executive's interests with those of shareholders, reinforcing the company's commitment to its leadership.
According to the filing dated November 6, 2026, Oldakowski acquired 186,403 shares of Class A common stock on November 4, 2026, through a time-based restricted stock unit award (RSUs). Following this transaction, he now owns a total of 462,300 shares in Clover Health Investments.
Background
Clover Health Investments, Inc. is a company incorporated in Delaware, primarily engaged in the healthcare sector, specifically under the SIC classification of Hospital & Medical Service Plans. The company trades under the ticker symbol CLOV on the exchanges. Recent filings indicate a focus on executive compensation and ownership structures, with the latest filing being a Form 4 submitted on November 6, 2026.
What the Filing Says
The filing states that Oldakowski's transaction involved acquiring shares with a transaction code of 'A', indicating an acquisition. The filing notes, "Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs)." It also outlines the vesting schedule for these RSUs, which will vest over a period of four years, contingent upon Oldakowski's continued service with the company.
Impact
This stock award may have implications for Clover Health's executive compensation strategy and could influence investor perceptions of the company's leadership alignment with shareholder interests. With Oldakowski now holding a significant number of shares, it may enhance confidence among investors regarding the company's direction and management.
What's Next
The filing does not say what happens next regarding further stock awards or changes in executive compensation. However, the vesting of the RSUs will continue over the next few years, contingent on Oldakowski's ongoing role within the company.
Read Next
Cheng Jordan Sells 2,800 Shares of Happen, Inc. Stock
Clover Health CFO Thornton acquires 328,947 shares via RSUs
Krouse Gifts 300 Shares of SBA Communications to Charity
Matinas BioPharma grants stock options to director Keith Murphy
Matinas BioPharma grants stock options to director D An Evelyn
Coastlands Capital LP Discloses Major Stake in Bolt Biotherapeutics









